These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 21225122

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63. Effect of botulinum toxin type a on tear production after treatment of lateral canthal rhytids.
    Arat YO, Yen MT.
    Ophthalmic Plast Reconstr Surg; 2007; 23(1):22-4. PubMed ID: 17237684
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy.
    Boroojerdi B, Ferbert A, Schwarz M, Herath H, Noth J.
    J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):111-4. PubMed ID: 9667571
    [Abstract] [Full Text] [Related]

  • 66. Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm.
    Karp BI, Alter K.
    Semin Neurol; 2016 Feb; 36(1):84-91. PubMed ID: 26866500
    [Abstract] [Full Text] [Related]

  • 67. Botulinum toxin for blepharospasm and hemifacial spasm: stability of duration of effect and dosage over time.
    Drummond GT, Hinz BJ.
    Can J Ophthalmol; 2001 Dec; 36(7):398-403. PubMed ID: 11794389
    [Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. [Botulinum toxin A: experience in the treatment of 115 patients].
    Andrade LA, Borges V, Ferraz HB, Azevedo-Silva SM.
    Arq Neuropsiquiatr; 1997 Sep; 55(3B):553-7. PubMed ID: 9629404
    [Abstract] [Full Text] [Related]

  • 70. [Safety and efficacy of botulinum toxin in hemifacial spasm].
    Mazlout H, Kamoun Gargouri H, Triki W, Kéfi S, Brour J, El Afrit MA, Chéour M, Kraiem A.
    J Fr Ophtalmol; 2013 Mar; 36(3):242-6. PubMed ID: 23270989
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction.
    Lew MF.
    Clin J Pain; 2002 Mar; 18(6 Suppl):S142-6. PubMed ID: 12569961
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Experience with long-term treatment with albumin-supplemented botulinum toxin type A.
    Mohammadi B, Kollewe K, Wegener M, Bigalke H, Dengler R.
    J Neural Transm (Vienna); 2009 Apr; 116(4):437-41. PubMed ID: 19319477
    [Abstract] [Full Text] [Related]

  • 75. Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment.
    Quagliato EM, Carelli EF, Viana MA.
    Clin Neuropharmacol; 2010 Apr; 33(1):27-31. PubMed ID: 20124784
    [Abstract] [Full Text] [Related]

  • 76. Blepharospasm and hemifacial spasm: long-term treatment with botulinum toxin.
    Gil Polo C, Rodríguez Sanz MF, Berrocal Izquierdo N, Castrillo Sanz A, Gutiérrez Ríos R, Zamora García MI, Mendoza Rodríguez A, Duarte García-Luis J.
    Neurologia; 2013 Apr; 28(3):131-6. PubMed ID: 22652139
    [Abstract] [Full Text] [Related]

  • 77. Botulinum toxin type B in blepharospasm and hemifacial spasm.
    Colosimo C, Chianese M, Giovannelli M, Contarino MF, Bentivoglio AR.
    J Neurol Neurosurg Psychiatry; 2003 May; 74(5):687. PubMed ID: 12700325
    [No Abstract] [Full Text] [Related]

  • 78. [Treatment of hemifacial spasm with botulinum A toxin].
    Duzyński W, Sławek J.
    Neurol Neurochir Pol; 1998 May; 32 Suppl 1():61-9. PubMed ID: 9608555
    [Abstract] [Full Text] [Related]

  • 79. [Long-term therapy of focal dystonia and facial hemispasm with botulinum toxin A].
    Vogt T, Lüssi F, Paul A, Urban P.
    Nervenarzt; 2008 Aug; 79(8):912-7. PubMed ID: 18551268
    [Abstract] [Full Text] [Related]

  • 80. A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm.
    Rieder CR, Schestatsky P, Socal MP, Monte TL, Fricke D, Costa J, Picon PD.
    Clin Neuropharmacol; 2007 Aug; 30(1):39-42. PubMed ID: 17272968
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.